Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+9.6%
5Y CAGR+35.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+9.6%/yr
Annual compound
5Y CAGR
+35.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
4.5x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$21.81M+6.8%
2024$20.42M+19.6%
2023$17.08M+3.1%
2022$16.57M+45.2%
2021$11.41M+137.8%
2020$4.80M+339.6%
2019$1.09M-